News and Trends 16 Nov 2020
Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up an emerging trend of harnessing…
Affimed
- Latest Posts
News and Trends 10 Oct 2018
Cancer Immunotherapy Phase I on Hold After Patient Death
The German biotech Affimed has halted two Phase I trials of its cancer immunotherapy after three patients suffered neurotoxicity due…
News and Trends 7 Jun 2017
What Cancer Therapies did European Biotechs Showcase at ASCO 2017?
Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO 2017 meeting in Chicago. European…
News and Trends 31 Mar 2016
The ‘Formative Year’ of Germany’s only NASDAQ-listed Biotech
Affimed from Heidelberg had a 'formative year' (hmm) in 2015. Major highlights include raising of €52.6M, expanding to the US and…
ADVERTISEMENT
News and Trends 23 Feb 2016
7 Trendy European Biotechs Listed on the NASDAQ in 2016
Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more depth; location, market cap and…
News and Trends 26 Jan 2016
Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial
Affimed in Heidelberg (Germany) will fund and conduct a clinical trial to investigate the combination of Merck's (MSD) anti-PD-1 therapy (Keytruda),…
News and Trends 24 Nov 2015
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
The World Leader in the Immuno-Oncology field has teamed up with a major German Investor to better identify breakthrough investment…
News and Trends 19 Oct 2015
Secret Shareholder racks up another €19.2M for Affimed’s Cancer Tandem Antibodies
Affimed Therapeutics is a clinical-stage biopharmaceutical company from Heidelberg (Germany) which is developing highly targeted cancer immunotherapies for some leukemias…
News and Trends 3 Sep 2014
Affimed secures almost $30M in Financing to continue its clinical development
Affimed Therapeutics today announced that it has closed a $15.7 million (€11.7 million) Series E equity funding led by Affimed’s…
